44,845 Shares in Acadia Healthcare Company, Inc. $ACHC Bought by The Manufacturers Life Insurance Company

Key Points

• The Manufacturers Life Insurance Company acquired 44,845 shares of Acadia Healthcare in the second quarter, valued at approximately $1.32 million. Several other institutional investors also initiated or expanded positions in the behavioral healthcare provider.
• Analyst sentiment is mixed but includes multiple recent price-target increases, with targets ranging from $32 to $40. MarketBeat’s overall rating remains “Hold,” with an average price target of $29.85.
• Acadia reported quarterly EPS of $0.38, exceeding the $0.35 consensus estimate, while revenue reached $865.84 million. However, revenue declined 0.4% year over year and the company posted a negative net margin of 33.44%.

The Manufacturers Life Insurance Company purchased a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 44,845 shares of the company's stock, valued at approximately $1,324,000.

A number of other large investors also recently modified their holdings of ACHC. Algert Global LLC purchased a new stake in shares of Acadia Healthcare during the 2nd quarter worth about $2,723,000. Cibc World Market Inc. purchased a new position in Acadia Healthcare in the second quarter valued at approximately $3,508,000. Bank of Nova Scotia acquired a new position in Acadia Healthcare during the second quarter valued at approximately $14,636,000. Quantbot Technologies LP purchased a new stake in Acadia Healthcare during the second quarter worth approximately $88,000. Finally, Evolve Private Wealth LLC acquired a new stake in shares of Acadia Healthcare in the second quarter worth $263,000.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Guggenheim raised their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a "buy" rating in a research note on Thursday, July 30th. UBS Group increased their price target on Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a report on Thursday, July 9th. TD Cowen boosted their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th. KeyCorp upped their target price on Acadia Healthcare from $30.00 to $40.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 14th. Finally, Barclays increased their target price on Acadia Healthcare from $25.00 to $32.00 and gave the company an "equal weight" rating in a research note on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $29.85.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $28.13 on Friday. The firm has a fifty day simple moving average of $30.70 and a 200-day simple moving average of $26.51. The company has a market capitalization of $2.62 billion, a PE ratio of -2.26, a price-to-earnings-growth ratio of 9.14 and a beta of 0.62. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $35.83. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.03. The firm had revenue of $865.84 million for the quarter, compared to analyst estimates of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm's revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source